Open help menu
Live Webinar

Getting Up To Date: New FDA Psychotropic Medication Approvals in the Last 18 Months

Toni Richardi, PsyD, MSCP
|

Pricing

Information

Date & Time

Learning Objectives

Participants will be able to:

  • Identify new psychotropic medications that have gained FDA approval within the last 18 months.

  • Describe the clinical uses for each new medication identified.

  • Explain the mechanism of action, common side effects, and any contraindications for new medications identified.

  • Describe the suggested titration and dosing for each new medication discussed.

  • Name new FDA approved uses within the last 18 months for already existing medications.

Educational Goal

The educational goal of this workshop is to provide participants with an understanding of the clinical uses, mechanisms of action, titration and dosing guidelines, common side effects, and contraindications associated with each new medication.

Description

This CE will focus on new psychotropic medications that have received FDA approval within the past 18 months. Because access to timely, comprehensive information about newly approved medications may be limited outside of pharmaceutical manufacturers and scientific literature, this workshop will provide an objective, clinically focused overview of these treatments. For each medication, participants will review the mechanism of action, FDA-approved clinical uses, dosing and titration considerations, common and clinically significant adverse effects, and relevant contraindications and precautions. The goal is to provide prescribing psychologists, psychologists, and other mental health professionals with current, practical information to support informed clinical decision-making and safe, effective patient care.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Toni Richardi, PsyD, MSCP
Toni Richardi, Psy.D., MSCP is a clinical psychologist in private practice based out of Asheville, NC. Dr. Richardi is licensed in Florida and North Carolina and credentialed through PSYPACT. She specializes in health psychology and clinical psychopharmacology. She is an instructor at Fairleigh Dickinson University's Master's in Clinical Psychopharmacology program and Clinical Psychology doctoral program.

Financially Sponsored By

  • Society for Prescribing Psychology